Corporate Culture

Broad & Great Enterprise is a CDMO company specializing in the R&D and manufacturing of chemical and biopharmaceutical drugs, strategically positioned around "one production base and two R&D platforms." The company is committed to building both an innovation chain and an industry-wide value chain. With R&D innovation as its core driving force, the company focuses on small-molecule chemical drugs and biotechnology. By adopting an integrated approach—combining raw material and formulation production—and leveraging innovative technology platforms for small-molecule APIs, along with a strategy that blends generic and innovative drug development, the company has established a robust product pipeline. This pipeline ensures sustained competitiveness over the medium to long term through a phased approach: developing one generation of products while simultaneously producing, stockpiling, and optimizing another. Additionally, the company has assembled a dedicated sales and marketing team and forged long-term partnerships with more than 100 GSP and CSO companies nationwide, enabling efficient drug promotion and commercialization.